Revvity Announces New License Agreement for Next-Generation

Non-exclusive agreement provides AstraZeneca access to proprietary gene editing technology to help advance its work in cell therapy


... | May 18, 2023

Related Keywords

Alan Fletcher , Instagram , Youtube , Revvity Inc , Life Sciences At Revvity , Twitter , Astrazeneca , Nasdaq , Facebook , Linkedin , Senior Vice President , Life Sciences , Perkinelmer , Nc Stock Exchange , News , Information , Press Release , Agreement , Rovides , Access , O , Roprietary , Gene , Editing , Technology , Help , Advance , Its , Work , N , Ell Rvty Us7140461093 ,